{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:04:20Z","timestamp":1781503460328,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00482-007-0564-1","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T12:24:56Z","timestamp":1186057496000},"page":"318-330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Von der Weidenrinde zu den Coxiben","From willow bark to the coxibs"],"prefix":"10.1007","volume":"21","author":[{"given":"K.","family":"Brune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Niederweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,4]]},"reference":[{"key":"564_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nn778","volume":"5","author":"Ahmadi","year":"2002","unstructured":"Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU (2002) PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci 5: 34\u201340","journal-title":"Nat Neurosci"},{"key":"564_CR2","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1126\/science.1083970","volume":"300","author":"Ahmadi","year":"2003","unstructured":"Ahmadi S, Muth-Selbach U, Lauterbach A et al. (2003) Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science 300: 2094\u20132097","journal-title":"Science"},{"key":"564_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0014-5793(96)00604-7","volume":"390","author":"Beiche","year":"1996","unstructured":"Beiche F, Scheuerer S, Brune K et al. (1996) Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 390: 162\u2013169","journal-title":"FEBS Lett"},{"key":"564_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF01965225","volume":"4","author":"Brune","year":"1974","unstructured":"Brune K (1974) How aspirin might work: a pharmakinetic approach. Agents Actions 4: 230\u2013232","journal-title":"Agents Actions"},{"key":"564_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1366-0071(97)80033-2","volume":"1","author":"Brune","year":"1997","unstructured":"Brune K (1997) The early history of non-opioid analgesics. Acute Pain 1: 33\u201340","journal-title":"Acute Pain"},{"key":"564_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00499844","volume":"315","author":"Brune","year":"1981","unstructured":"Brune K, Rainsford KD, Wagner K, Peskar BA (1981) Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol 315: 269\u2013276","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"564_CR7","doi-asserted-by":"crossref","unstructured":"Brune K, Zeilhofer HU (2005) Antipyretic analgesics: basic aspects. In: Mc Mahon SB, Koltzenberg M (eds) Wall and Melzack\u2019s textbook of pain. Elsevier, Amsterdam, pp 459\u2013469","DOI":"10.1016\/B0-443-07287-6\/50034-5"},{"issue":"6","key":"564_CR8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/rheumatology\/kem070","volume":"46","author":"K Brune","year":"2007","unstructured":"Brune K, Furst D (2007) Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability? Rheumatology (Oxford) 46(6): 911\u2013919","journal-title":"Rheumatology (Oxford)"},{"key":"564_CR9","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/art.20424","volume":"50","author":"Brune","year":"2004","unstructured":"Brune K, Hinz B (2004) The discovery and development of antiinflammatory drugs. Arthritis Rheum 50: 2391\u20132399","journal-title":"Arthritis Rheum"},{"key":"564_CR10","unstructured":"Cahn A, Hepp P (1985) Das Antifebrin, ein neues Fiebermittel. Centralbl Klein Med 1886: 561\u2013564. In: Sneader W (ed) Drug discovery: the evolution of modern medicines. Wiley & Sons, Chichester, pp\u00a085\u201386"},{"key":"564_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1081\/JAS-200051326","volume":"42","author":"Celik","year":"2005","unstructured":"Celik G, Pasaoglu G, Bavbek S et al. (2005) Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance. J Asthma 42: 127\u2013131","journal-title":"J Asthma"},{"key":"564_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1677\/jme.0.0160107","volume":"16","author":"Chakraborty","year":"1996","unstructured":"Chakraborty I, Das SK, Wang J, Dey SK (1996) Developmental expression of the cyclooxygenase-1 and cyclooxygenase-2 genes in the periimplantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol 16: 107\u2013122","journal-title":"J Mol Endocrinol"},{"key":"564_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00003088-199936030-00002","volume":"36","author":"Day","year":"1999","unstructured":"Day RO, McLachlan AJ, Graham GG, Williams KM (1999) Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 36: 191\u2013210","journal-title":"Clin Pharmacokinet"},{"key":"564_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1468-2982.2005.00948.x","volume":"25","author":"Diener","year":"2005","unstructured":"Diener HC, Pfaffenrath V, Pageler L et al. (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25: 776\u2013787","journal-title":"Cephalalgia"},{"key":"564_CR15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0022-3565(24)37497-X","volume":"285","author":"Dirig","year":"1998","unstructured":"Dirig DM, Isakson PC, Yaksh TL (1998) Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 285: 1031\u20131038","journal-title":"J Pharmacol Exp Ther"},{"key":"564_CR16","doi-asserted-by":"crossref","unstructured":"Dreser H (1899) Pharmakologisches \u00fcber Aspirin (Acetylsalicyls\u00e4ure). Pfl\u00fcger\u2019s Arch Gesamte Physiol Menschen Tiere 76: 306\u2013318","DOI":"10.1007\/BF01662127"},{"key":"564_CR17","first-page":"390","volume":"3","author":"Dreser","year":"1907","unstructured":"Dreser H (1907) \u00dcber modifizierte Salizyls\u00e4uren. Med Klinik 3: 390\u2013393","journal-title":"Med Klinik"},{"key":"564_CR18","first-page":"16","volume":"45","author":"Filehne","year":"1882","unstructured":"Filehne W (1882) Weiteres \u00fcber Kairin und analoge K\u00f6rper. Berl Klein Wochenschr 45: 16\u201318","journal-title":"Berl Klein Wochenschr"},{"key":"564_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJM200108093450607","volume":"345","author":"FitzGerald","year":"2001","unstructured":"FitzGerald GA, Patrono C (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345: 433\u2013442","journal-title":"N Engl J Med"},{"key":"564_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrd1034","volume":"2","author":"Flower","year":"2003","unstructured":"Flower RJ (2003) The development of COX2 inhibitors. Nat Rev Drug Discov 2: 179\u2013191","journal-title":"Nat Rev Drug Discov"},{"key":"564_CR21","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1073\/pnas.93.3.1108","volume":"93","author":"Gold","year":"1996","unstructured":"Gold MS, Reichling DB, Shuster MJ, Levine JD (1996) Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A 93: 1108\u20131112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"564_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/BF02358871","volume":"31","author":"Graf","year":"1975","unstructured":"Graf P, Glatt M, Brune K (1975) Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experienta 31: 951\u2013953","journal-title":"Experienta"},{"key":"564_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI27291","volume":"116","author":"Grosser","year":"2006","unstructured":"Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116: 4\u201315","journal-title":"J Clin Invest"},{"key":"564_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1126\/science.1094925","volume":"304","author":"Harvey","year":"2004","unstructured":"Harvey RJ, Depner UB, Wassle H et al. (2004) GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 304: 884\u2013887","journal-title":"Science"},{"key":"564_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/jpet.300.2.367","volume":"300","author":"Hinz","year":"2002","unstructured":"Hinz B, Brune K (2002) Cyclooxygenase-2 \u2013 10 years later. J Pharmacol Exp Ther 300: 367\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"564_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/art.21540","volume":"54","author":"Hinz","year":"2006","unstructured":"Hinz B, Dormann H, Brune K (2006) More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib. Arthritis Rheum 54: 282\u2013291","journal-title":"Arthritis Rheum"},{"key":"564_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-540-33823-9_3","volume":"177","author":"Hinz","year":"2007","unstructured":"Hinz B, Brune K (2007) Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handb Exp Pharmacol 177: 65\u201393","journal-title":"Handb Exp Pharmacol"},{"key":"564_CR28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0085-2538(15)46757-2","volume":"57","author":"K\u00f6mhoff","year":"2000","unstructured":"K\u00f6mhoff M, Wang JL, Cheng HF et al. (2000) Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57: 414\u2013422","journal-title":"Kidney Int"},{"key":"564_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01966686","volume":"17","author":"Liauw","year":"1985","unstructured":"Liauw HL, Ku E, Brandt KD et al. (1985) Effects of voltaren on arachidonic acid metabolism in arthritis patients. Agents Actions 17: 195\u2013199","journal-title":"Agents Actions"},{"key":"564_CR30","first-page":"383","volume":"342","author":"Mac","year":"1876","unstructured":"Mac Lagan TJ (1876) The treatment of acute rheumatism by salicin. Lancet 342: 383","journal-title":"Lancet"},{"key":"564_CR31","first-page":"2616","volume":"42","author":"Maih\u00f6fner","year":"2001","unstructured":"Maih\u00f6fner C, Schl\u00f6tzer-Schrehardt U, G\u00fchring H et al. (2001) Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci 42: 2616\u20132624","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"564_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1073\/pnas.96.1.272","volume":"96","author":"McAdam","year":"1999","unstructured":"McAdam BF, Catella-Lawson F, Mardini IA et al. (1999) Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 96: 272\u2013277","journal-title":"Proc Natl Acad Sci U S A"},{"key":"564_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2474-7-79","volume":"7","author":"Moore","year":"2006","unstructured":"Moore RA, Derry S, Phillips CJ, McQuay HJ (2006) Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. BMC Musculoskelet Disord 7: 79; published online","journal-title":"BMC Musculoskelet Disord"},{"key":"564_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","volume":"83","author":"Morham","year":"1995","unstructured":"Morham SG, Langenbach R, Loftin CD et al. (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473\u2013482","journal-title":"Cell"},{"key":"564_CR35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","volume":"79","author":"Narumiya","year":"1999","unstructured":"Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193\u20131226","journal-title":"Physiol Rev"},{"key":"564_CR36","unstructured":"Rainsford KD (ed) (1984) Aspirin and salicylates. Butterworth, London, pp\u00a02\u20133"},{"key":"564_CR37","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1523\/JNEUROSCI.22-11-04740.2002","volume":"22","author":"Rathee","year":"2002","unstructured":"Rathee PK, Distler C, Obreja O et al. (2002) PKA\/AKAP\/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 22: 4740\u20134745","journal-title":"J Neurosci"},{"key":"564_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1172\/JCI200523618","volume":"115","author":"Reinold","year":"2005","unstructured":"Reinold H, Ahmadi S, Depner UB et al. (2005) Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 115: 673\u2013679","journal-title":"J Clin Invest"},{"key":"564_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/35068566","volume":"410","author":"Samad","year":"2001","unstructured":"Samad TA, Moore KA, Sapirstein A et al. (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471\u2013475","journal-title":"Nature"},{"key":"564_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1067\/mcp.2002.126182","volume":"72","author":"Schwartz","year":"2002","unstructured":"Schwartz JI, Vandormael K, Malice MP et al. (2002) Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 72: 50\u201361","journal-title":"Clin Pharmacol Ther"},{"key":"564_CR41","unstructured":"Sert\u00fcrner FW (1806) Darstellung der reinen Mohns\u00e4ure (Opiums\u00e4ure) nebst einer chemischen Untersuchung des Opiums mit vorz\u00fcglicher Hinsicht auf einen darin neu entdeckten Stoff und die dahin geh\u00f6rigen Bemerkungen. Journal der Pharmacie f\u00fcr Aerzte, Apotheker und Chemisten 14"},{"key":"564_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387\u2013437","journal-title":"Pharmacol Rev"},{"key":"564_CR43","unstructured":"Sneader W (ed) (1985) Drug discovery: the evaluation of modern medicines. Wiley & Sons, Chichester"},{"key":"564_CR44","first-page":"195","volume":"53","author":"Stone","year":"1763","unstructured":"Stone E (1763) An account of the success of the bark of the willow in the cure of agues. Phil Trans R Soc Lond 53: 195\u2013200","journal-title":"Phil Trans R Soc Lond"},{"key":"564_CR45","first-page":"1","volume":"13","author":"Stricker","year":"1876","unstructured":"Stricker S (1876) Aus der Traub\u00e9schen Klinik. Ueber die Resultate der Behandlung der Polyarthritis rheumatica mit Salicylsa\u00fcre. Berl Klein Wochenschr 13: 1\u20132; 15\u201316; 99\u2013103","journal-title":"Berl Klein Wochenschr"},{"key":"564_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1749-6632.1948.tb27246.x","volume":"51","author":"Tainter","year":"1984","unstructured":"Tainter ML (1984) Pain. Ann NY Acad Sci 51: 3\u201311","journal-title":"Ann NY Acad Sci"},{"key":"564_CR47","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1073\/pnas.1332766100","volume":"100","author":"Trebino","year":"2003","unstructured":"Trebino CE, Stock JL, Gibbons CP et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A 100: 9044\u20139049","journal-title":"Proc Natl Acad Sci U S A"},{"key":"564_CR48","unstructured":"Vane JR, Botting RM (eds) (1992) Aspirin and other salicylates. Chapman & Hall, London"},{"key":"564_CR49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"Vane","year":"1971","unstructured":"Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nat New Biol 231: 232\u2013235","journal-title":"Nat New Biol"},{"key":"564_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000098658","volume":"143","author":"Viola","year":"2007","unstructured":"Viola M, Quaratino D, Gaeta F et al. (2007) Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 143: 103\u2013108","journal-title":"Int Arch Allergy Immunol"},{"key":"564_CR51","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1523\/JNEUROSCI.22-15-06704.2002","volume":"22","author":"Weidner","year":"2002","unstructured":"Weidner C, Schmelz M, Schmidt R et al. (2002) Neural signal processing: the underestimated contribution of peripheral human C-fibers. J Neurosci 22: 6704\u20136712","journal-title":"J Neurosci"},{"key":"564_CR52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","volume":"Biol","author":"Winter","year":"1962","unstructured":"Winter CA, Risley EA, Nuss GW (1962) Carrageenan-induced edema in hindpaw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol (NY) 111: 544\u2013547","journal-title":"Proc Soc Exp"},{"key":"564_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tips.2006.07.007","volume":"27","author":"Zeilhofer","year":"2006","unstructured":"Zeilhofer HU, Brune K (2006) Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci 27: 467\u2013474","journal-title":"Trends Pharmacol Sci"},{"key":"564_CR54","first-page":"21","volume":"1","author":"Zimmermann","year":"1982","unstructured":"Zimmermann M (1982) Periphere Mechanismen von Schmerz und Schmerztherapie. Sandorama 1: 21\u201326","journal-title":"Sandorama"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-007-0564-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-007-0564-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-007-0564-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-007-0564-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:39:22Z","timestamp":1737340762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-007-0564-1"}},"subtitle":["Entwicklung der antiphlogistischen Analgetika","Development of antiphlogistic analgesics"],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s00482-007-0564-1","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"4 August 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}